Related Experiment Video
Updated: May 13, 2026

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tamara Tchkonia1, Yi Zhu, Jan van Deursen
1Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota 55905, USA.
Abstract:
Aging is the largest risk factor for most chronic diseases, which account for the majority of morbidity and health care expenditures in developed nations. New findings suggest that aging is a modifiable risk factor, and it may be feasible to delay age-related diseases as a group by modulating fundamental aging mechanisms. One such mechanism is cellular senescence, which can cause chronic inflammation through the senescence-associated secretory phenotype (SASP). We review the mechanisms that induce senescence and the SASP, their associations with chronic disease and frailty, therapeutic opportunities based on targeting senescent cells and the SASP, and potential paths to developing clinical interventions.
Insights
Aging is a modifiable risk factor for chronic diseases. Targeting cellular senescence and its associated inflammatory pathways offers a promising strategy to delay multiple age-related conditions and improve healthspan.
Area of Science:
- Gerontology and cellular biology.
- Immunology and chronic disease research.
Background:
- Aging is the primary risk factor for numerous chronic diseases, driving significant healthcare costs.
- Chronic diseases and frailty are major burdens in developed nations, linked to aging processes.
Purpose of the Study:
- To explore aging as a modifiable risk factor for age-related diseases.
- To review the role of cellular senescence and the senescence-associated secretory phenotype (SASP) in aging and disease.
- To discuss therapeutic strategies targeting senescent cells and SASP for clinical intervention.
Main Methods:
- Review of existing literature on aging mechanisms, cellular senescence, and SASP.
- Analysis of the association between senescence, SASP, chronic diseases, and frailty.
- Exploration of current and potential therapeutic interventions targeting senescent cells.
Main Results:
- Cellular senescence, characterized by the SASP, contributes to chronic inflammation.
- The SASP is implicated in the pathogenesis of various age-related chronic diseases and frailty.
- Targeting senescent cells presents a viable therapeutic avenue for age-related conditions.
Conclusions:
- Modulating fundamental aging mechanisms, specifically cellular senescence, may delay multiple chronic diseases simultaneously.
- Therapeutic strategies focused on senescent cells and SASP hold promise for improving healthspan and treating age-related pathologies.
- Further research into clinical interventions targeting senescence is warranted.
Related Concept Videos
Replicative Cell Senescence
Replicative Cell Senescence
Cellular Injury V: Apoptosis and Autophagy
Mitochondria
Cellular Adaptation I: Introduction and Atrophy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

